BioSpace News Archive

Drug Development

Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Demonstrates Durable Four-Year Survival Benefits in Patients with Advanced Melanoma

More than half (53%) of patients treated with Opdivo plus Yervoy survived to four years, with median overall survival (OS) not yet reached

October 22, 2018
·
37 min read
BioForest

Aortica™ Corp. Announces Publication of Successful Results Demonstrating Simplification of Fenestrated EVAR Using AortaFit™ Automated Case Planning Software

Dr. Benjamin Starnes’ PS-IDE Study Results published in Journal of Vascular Surgery

October 22, 2018
·
4 min read
Lone Star Bio

RETINA-AI Releases Android Version of Fluid-Intelligence -- World’s First Mobile Artificial Intelligence App for Eye Care Providers

RETINA-AI has released an Android version of its app Fluid-Intelligence, the world’s first mobile artificial intelligence (AI) app for eye care providers. The app can be downloaded here: Google Play Store and App Store.

October 22, 2018
·
2 min read
Business

Kazia Enters Clinical Collaboration to Investigate Use of Brain Cancer Drug GDC-0084 in Breast Cancer

Kazia Therapeutics announced today that it will collaborate with world-leading treatment and research centre Dana-Farber Cancer Institute to investigate the use of Kazia’s potential new therapy for brain cancer, GDC-0084, in breast cancer that has spread to the brain.

October 22, 2018
·
4 min read
Drug Development

Mirati Therapeutics Presents Updated Positive Clinical Data From Sitravatinib Immuno-Oncology Combination Trial At ESMO 2018 Congress And Announces FDA Guidance For Registration Trial

Updated analysis from ongoing Phase 2 trial of sitravatinib in combination with nivolumab demonstrated significant clinical activity in patients with checkpoint refractory non-small cell lung cancer (NSCLC)

October 22, 2018
·
8 min read
Policy

Sinovac Granted Interim Injunctive Relief Regarding Filings Bearing a Falsified Company Seal and Forged Board Member Signatures

Senior management of Sinovac Biotech Ltd. and the lawful directors of Sinovac Hong Kong (“Lawful Directors”), Mr. Yin Weidong and Ms. Wang Nan, have been granted interim injunctive relief against Mr. Li Pengfei (“Mr. Li”) and Mr. Cao Jianzeng (“Mr. Cao”) by the High Court of the Hong Kong Special Administrative Region

October 22, 2018
·
4 min read
Drug Development

Medicenna Presented Insights from the Phase 2b Clinical Trial of MDNA55 at the European Society for Medical Oncology 2018 Congress

Dr. Martin Bexon, Head of Clinical Development at Medicenna, presented results outlining the patterns of responses seen in the MDNA55 Phase 2b clinical trial in patients treated at low doses implemented during the first half of the study.

October 22, 2018
·
5 min read
Policy

European Medicines Agency Adopts Positive Opinion for Merck’s KEYTRUDA® (pembrolizumab) as Adjuvant Therapy in Melanoma

Opinion Granted Based on Significant Recurrence-Free Survival Benefit Demonstrated with KEYTRUDA in Pivotal Phase 3 EORTC1325/KEYNOTE-054 Trial

October 22, 2018
·
25 min read
Real Farm Lives: New documentary series shows how food finds its way to Canadians

A recent survey from the Canadian Centre for Food Integrity reveals that most Canadians are disconnected from the people who grow their food and how it is grown.

October 22, 2018
·
3 min read
Biotech Beach

DenMat Holdings, LLC Launches New Website

DenMat Holdings, LLC (“DenMat”) announces the launch of the newly redesigned DenMat.com.

October 22, 2018
·
2 min read